SLC16A1 and cancer: When the overall cohort was stratified according to grade (I/II vs III), similar to the unadjusted model, an increased trend towards reduced recurrence free, cancer specific and overall survival was observed in patients with high MCT1 expressing grade III (mainly composed of Non-EEC) tumours (Fig. 3d-f).